Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DINUP: Sitagliptin and NB-UVB in Psoriasis
NCT02347501Phase 2Completed
- Sponsor
- University College Dublin
- Start
- Nov 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sitagliptin in psoriasis (2 arms), sponsored by University College Dublin. Primary endpoint: Psoriasis Area and Severity Index at 24 weeks. Started Nov 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02347501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347501.